Literature DB >> 25091008

Prostate cancer: alkaline phosphatase velocity in nonmetastatic CRPC.

Yao Zhu1, Ding-Wei Ye2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25091008     DOI： 10.1038/nrurol.2014.192

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update.

Authors:  Fred Saad; Sebastien Hotte; Charles Catton; Darrel Drachenberg; Antonio Finelli; Neil Fleshner; Martin Gleave; Anil Kapoor; Wassim Kassouf; Andrew Loblaw; Scott North; Nawaid Usmani; Kim N Chi
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

2.  Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Authors:  Matthew R Smith; Fairooz Kabbinavar; Fred Saad; Arif Hussain; Marc C Gittelman; David L Bilhartz; Chris Wynne; Robin Murray; Norman R Zinner; Claude Schulman; Ronald Linnartz; Ming Zheng; Carsten Goessl; Yong-Jiang Hei; Eric J Small; Richard Cook; Celestia S Higano
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

3.  Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer.

Authors:  Adam R Metwalli; Inger L Rosner; Jennifer Cullen; Yongmei Chen; Timothy Brand; Stephen A Brassell; James Lesperance; Christopher Porter; Joseph Sterbis; David G McLeod
Journal:  Urol Oncol       Date:  2014-06-11       Impact factor: 3.498

4.  Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Authors:  Matthew R Smith; Fred Saad; Robert Coleman; Neal Shore; Karim Fizazi; Bertrand Tombal; Kurt Miller; Paul Sieber; Lawrence Karsh; Ronaldo Damião; Teuvo L Tammela; Blair Egerdie; Hendrik Van Poppel; Joseph Chin; Juan Morote; Francisco Gómez-Veiga; Tomasz Borkowski; Zhishen Ye; Amy Kupic; Roger Dansey; Carsten Goessl
Journal:  Lancet       Date:  2011-11-15       Impact factor: 79.321

5.  Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer.

Authors:  Matthew R Smith; Richard Cook; Ker-Ai Lee; Joel B Nelson
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

6.  Prostate cancer, version 2.2014.

Authors:  James L Mohler; Philip W Kantoff; Andrew J Armstrong; Robert R Bahnson; Michael Cohen; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas A Farrington; Celestia S Higano; Eric Mark Horwitz; Christopher J Kane; Mark H Kawachi; Michael Kuettel; Timothy M Kuzel; Richard J Lee; Arnold W Malcolm; David Miller; Elizabeth R Plimack; Julio M Pow-Sang; David Raben; Sylvia Richey; Mack Roach; Eric Rohren; Stan Rosenfeld; Edward Schaeffer; Eric J Small; Guru Sonpavde; Sandy Srinivas; Cy Stein; Seth A Strope; Jonathan Tward; Dorothy A Shead; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2014-05       Impact factor: 11.908

7.  Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.

Authors:  Matthew R Smith; Fred Saad; Stephane Oudard; Neal Shore; Karim Fizazi; Paul Sieber; Bertrand Tombal; Ronaldo Damiao; Gavin Marx; Kurt Miller; Peter Van Veldhuizen; Juan Morote; Zhishen Ye; Roger Dansey; Carsten Goessl
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

8.  Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.

Authors:  Choichiro Ozu; Jun Nakashima; Yutaka Horiguchi; Mototsugu Oya; Takashi Ohigashi; Masaru Murai
Journal:  Int J Urol       Date:  2008-05       Impact factor: 3.369
  8 in total
  1 in total

1.  Elucidation and control of low and high active populations of alkaline phosphatase molecules for quantitative digital bioassay.

Authors:  Hiroshi Ueno; Makoto Kato; Yoshihiro Minagawa; Yushi Hirose; Hiroyuki Noji
Journal:  Protein Sci       Date:  2021-06-09       Impact factor: 6.725
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.